Molecular basis of muscular dystrophies

Muscle and Nerve

Volumn 23, Issue 10, 2000, Pages 1456-1471

  Cohn, Ronald D ^a   Campbell, Kevin P ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cardiomyopathy; Dystrophin glycoprotein complex; Laminin; Muscular dystrophy; Sarcoglycan

Indexed keywords

CALPAIN; CAVEOLIN; COLLAGEN TYPE 6; DYSTROPHIN; EMERIN; INTEGRIN; LAMININ; MUSCLE PROTEIN; SARCOGLYCAN;

DUCHENNE MUSCULAR DYSTROPHY; EMERY DREIFUSS MUSCULAR DYSTROPHY; GENE MUTATION; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCULAR DYSTROPHY; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PRIORITY JOURNAL; REVIEW;

HUMAN; MUSCLES; MUSCULAR DYSTROPHIES; SUPPORT, NON-U.S. GOV'T;

EID: 0033814140     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T     Document Type: Review

References (136)

1. A nematode gene required for sperm vesicle fusion
2. Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain
3. Utrophin lacks the rod domain actin binding activity of dystrophin
4. A cluster of basic repeats in the dystrophin rod domain binds F-actin through an electrostatic interaction
5. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A
6. Dysferlin is a plasma membrane protein and is expressed early in human development
7. Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice
8. The fukutin protein family - Predicted enzymes modifying cell-surface molecules
9. Further investigations on benign myopathy with autosomal dominant inheritance
10. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A
11. Concomitant deficiency of beta- and gamma-sarcoglycans in 20 alpha-sarcoglycan (adhalin)-deficient patients: Immunohistochemical analysis and clinical aspects
12. Use of a CEPH meiotic breakpoint panel to refine the locus of limb-girdle muscular dystrophy type 1A (LGMD1A) to a 2-Mb interval on 5q31
13. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B
14. A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage
15. Benign myopathy, with autosomal dominant inheritance. A report on three pedigrees
16. Ecto-ATPase activity of alpha-sarcoglycan (adhalin)
17. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy
18. Identification of new mutations in the Emery-Dreifuss muscular dystrophy gene and evidence for genetic heterogeneity of the disease
19. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B
20. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy
21. Limb-girdle muscular dystrophies: An overview
22. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy
23. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy
24. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member
25. Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage
26. Association of dystrophin and an integral membrane glycoprotein
27. Heart-specific localization of emerin: New insights into Emery-Dreifuss muscular dystrophy
28. Molecular organization of sarcoglycan complex in mouse myotubes in culture
29. Laminin alpha2 chain-deficient congenital muscular dystrophy: Variable epitope expression in severe and mild cases
30. Changes of laminin beta 2 chain expression in congenital muscular dystrophy
31. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle
32. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy
33. Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage analysis and homozygosity mapping
34. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses
35. Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex
36. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex
37. Mdx muscle pathology is independent of nNOS perturbation
38. Caveolin-3 is not an integral component of the dystrophin glycoprotein complex
39. Myoferlin, a candidate gene and potential modifier of muscular dystrophy
40. 41st ENMC international workshop on congenital muscular dystrophy, 8-10 March 1996, Naarden, The Netherlands
41. Workshop report: Proceedings on the 27th ENMC sponsored workshop on congenital muscular dystrophy
42. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice
43. Biochemical characterization of the epithelial dystroglycan complex
44. Disruption of the β-sarcoglycan gene reveals a complex pathogenetic mechansim for LGMD 2E
45. Unusual type of benign x-linked muscular dystrophy
46. Membrane organization of the dystrophin-glycoprotein complex
47. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin
48. Purification of dystrophin from skeletal muscle
49. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
50. Epsilon-sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D
51. The Emery-Dreifuss muscular dystrophy phenotype arises from aberrant targeting and binding of emerin at the inner nuclear membrane
52. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease
53. Congenital progressive muscular dystrophy of the Fukuyama type: Clinical, genetic and pathological considerations
54. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex
55. Cardiomyopathy in Duchenne, Becker and sarcoglycanopathies: A role for coronary dysfunction?
56. Calpain activity promotes the sealing of severed giant axons
57. Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies
58. Muscle assembly: A titanic achievement?
59. Muscle degeneration without mechanical injury in sarcoglycan deficiency
60. Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin
61. Muscle-eyebrain disease: A neuropathological study
62. Mutations in the integrin alpha7 gene cause congenital myopathy
63. Abnormal localization of laminin subunits in muscular dystrophies
64. Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies
65. Assembly of the sarcoglycan complex. Insights for muscular dystrophy
66. Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer
67. Resealing of transected myelinated mammalian axons in vivo: Evidence for involvement of calpain
68. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
69. Electron microscopic examination of basal lamina in Fukuyama congenital muscular dystrophy
70. Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures
71. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan
72. Muscle-specific calpain, p94, interacts with the extreme C-terminal region of connectin, a unique region flanked by two immunoglobulin C2 motifs
73. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
74. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein
75. Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD)
76. Reduced collagen VI causes Bethlem myopathy: A heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency
77. Bethlem myopathy and engineered collagen VI triple helical deletions prevent intracellular multimer assembly and protein secretion
78. Sarcospan-deficient mice maintain normal muscle function
79. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development
80. The sarcoglycan complex in limb-girdle muscular dystrophy
81. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy
82. Sarcoglycan isoforms in skeletal muscle
83. Mutations in Emery-Dreifuss muscular dystrophy and their effects on emerin protein expression
84. Synaptic integrins in developing, adult, and mutant muscle: Selective association of alpha1, alpha7A, and alpha7B integrins with the neuromuscular junction
85. Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy
86. Abnormal expression of dystrophin-associated proteins in Fukuyama-type congenital muscular dystrophy
87. Structural basis for activation of the titin kinase domain during myofibrillogenesis
88. Absence of integrin alpha 7 causes a novel form of muscular dystrophy
89. Differential heparin sensitivity of alpha-dystroglycan binding to laminins expressed in normal and dy/dy mouse skeletal muscle
90. Caveolin-3 in muscular dystrophy
91. Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene
92. Decreased expression of laminin beta 1 in chromosome 21-linked Bethlem myopathy
93. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23
94. Emery-Dreifuss muscular dystrophy with autosomal dominant transmission
95. Roles for laminin in embryogenesis: Exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain
96. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy
97. Organization of the myotendinous junction is dependent on the presence of alpha7beta1 integrin
98. Identification of a new locus for a peculiar form of congenital muscular dystrophy with early rigidity of the spine, on chromosome 1p35-36
99. The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q1 1-12
100. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin
101. Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy
102. Are breaches in the glia limitans the primary cause of the micropolygyria in Fukuyama-type congenital muscular dystrophy (FCMD)? Pathological study of the cerebral cortex of an FCMD fetus
103. Differential heparin inhibition of skeletal muscle alpha-dystroglycan binding to laminins
104. Missense mutation in avon Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy
105. Dystrophin protects the sarcolemma frown stresses developed during muscle contraction
106. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis
107. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy
108. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A
109. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice
110. A new model for the interaction of dystrophin with F-actin
111. Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association
112. Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes
113. Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin alpha 2 chain
114. Plectin deficiency results in muscular dystrophy with epidermolysis bullosa
115. Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence
116. Identification of a new autosomal dominant limb-girdle muscular dystrophy locus on chromosome 7
117. Epsilon-sarcoglycan replaces alpha-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex
118. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption
119. Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency
120. Presence of laminin alpha5 chain and lack of laminin alpha1 chain during human muscle development and in muscular dystrophies
121. The Peter Emil Becker Award lecture 1998. The saga of congenital muscular dystrophy
122. Congenital muscular dystrophy with merosin deficiency
123. Tibial muscular dystrophy - From clinical description to linkage on chromosome 2q31
124. Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy
125. Further evidence for the organisation of the four sarcoglycans proteins within the dystrophin-glycoprotein complex
126. Telethonin, a novel sarcomeric protein of heart and skeletal muscle
127. Genetic localisation of a newly recognised autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21
128. Congenital muscular dystrophies: 1997 Update
129. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s)
130. A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: Evidence for another limb-girdle muscular dystrophy locus
131. Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions
132. Fine mapping of the FSHD gene region orientates the rearranged fragment detected by the probe p13E-11
133. SH3 domain-mediated interaction of dystroglycan and Grb2
134. A dystrophin-associated glycoprotein, A3a (one of 43DAG doublets), is retained in Duchenne muscular dystrophy muscle
135. Glycoprotein complex anchoring dystrophin to sarcolemma